OAKLAND, CA – Ananya Health is proud to announce a new strategic investment from BrightEdge, the American Cancer Society’s impact investment and venture capital arm.

BrightEdge invests in companies advancing breakthrough cancer-focused technologies with the potential to save lives and reduce health disparities. Ananya is one of twelve companies selected for the 2025 BrightEdge Entrepreneurs program, which provides early-stage funding, strategic guidance, and access to the American Cancer Society’s nationwide network of cancer researchers, clinicians, and care sites.

This investment will support Ananya Health’s commercial readiness efforts as the company prepares for FDA submission in 2026. The company’s CRCL cryoablation platform is designed to expand access to treatment for cervical pre-cancer at the point of care, particularly in communities where access to timely follow-up and specialist care remains limited.

"We are honored to be selected by BrightEdge and to join a cohort of mission-aligned founders working to accelerate innovation in cancer care,” said Anu Parvatiyar, co-founder and CEO of Ananya Health. “This partnership will help us advance toward our goal of making cervical cancer treatment safer, more accessible, and more equitable worldwide.”

The team at Ananya Health congratulates its fellow cohort members and is looking forward to the collaborative year ahead.

 

About Ananya Health

Ananya Health is building a self-contained cryoablation platform to freeze abnormal cells in the cervix and prevent them from becoming cervical cancer, without any consumable cryogen. The company’s initial device enables standard of care outcomes at one-tenth the cost of traditional cryo at the primary care level without needing supplies of CO2 or N2. To learn more, follow Ananya Health on Instagram @ananyahealth or visit www.ananya.health.

​

About BrightEdge
BrightEdge is the American Cancer Society’s mission-driven venture capital fund, investing in innovative companies that aim to reduce the cancer burden and advance health equity. By supporting cutting-edge solutions across prevention, detection, and treatment, BrightEdge drives impact at scale and accelerates the ACS mission to improve the lives of cancer patients and their families. Learn more about ACS BrightEdge at https://acsbrightedge.org/.

Contact
Please direct inquiries to hi@ananya.health.